Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Seminars in Cancer Biology|August 28, 2019
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapyPaola Aiello, Sara Consalvi, Giovanna Poce, et al.European Journal of Medicinal Chemistry|September 14, 2021
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesisSara Consalvi, Giulia Venditti, Junhao Zhu, et al.Journal of Pharmacological Sciences|August 11, 2012
In vitro effects of VA441, a new selective cyclooxygenase-2 inhibitor, on human osteoarthritic chondrocytes exposed to IL-1βAntonella Fioravanti, Laura Tinti, Nicola Antonio Pascarelli, et al.Chemmedchem|May 28, 2016
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking AnalysisSara Consalvi, Giovanna Poce, Rino Ragno, et al.European Journal of Medicinal Chemistry|November 10, 2020
Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosisSara Consalvi, Giovanna Poce, Carla Ghelardini, et al.Journal of Chemical Information and Modeling|April 27, 2013
Pharmacophore assessment through 3-D QSAR: evaluation of the predictive ability on new derivatives by the application on a series of antitubercular agentsLaura Friggeri, Flavio Ballante, Rino Ragno, et al.Bioorganic & Medicinal Chemistry Letters|August 23, 2011
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cellsMarco Radi, Chiara Brullo, Emmanuele Crespan, et al.European Journal of Medicinal Chemistry|January 17, 2018
In vivo potent BM635 analogue with improved drug-like propertiesGiovanna Poce, Martina Cocozza, Salvatore Alfonso, et al.Chemmedchem|June 5, 2013
Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallographyPaola Baiocco, Giovanna Poce, Salvatore Alfonso, et al.Chemmedchem|July 2, 2013
Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agentsCristina Tintori, Ilaria Laurenzana, Francesco La Rocca, et al.Pageof 7